ResearcherHokkaido UniversityNo recent work listed

Takeo Nitta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8725-2857; OpenAlex author ID A5045784759. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2017: 1 paper

Papers 1

The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal aden… Co-author DOI 10.1007/s00595-016-1420-7 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Toshiaki Shichinohe · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗
Yoshitsugu Nakanishi · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗
Takahiro Tsuchikawa · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗
Toshimichi Asano · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗
Toru Nakamura · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗
Satoshi Hirano · 1 shared paper, 2017 · strength 0.06
- Paper The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreatic… DOI 10.1007/s00595-016-1420-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.